---  
layout: startup_page  
title: "LoQus23 Therapeutics"  
id: "loqus23.com"  
permalink: "/loqus23therapeuticsloqus23.com10022024/"  
website: "https://www.loqus23.com/"  
funding_round: "Series A"  
funding_amount: "$43M"  
investors: "Forbion, SV Health Investors' Dementia Discovery Fund (DDF), Novartis Venture Fund (NVF)"  
about: "LoQus23 Therapeutics is a biotechnology company developing small molecule drugs to stop DNA instability and slow neurodegeneration in Huntington's Disease and similar triplet repeat expansion diseases. Their lead program targets MutSÎ², aiming to provide a potentially disease-modifying therapy. The company utilizes a structure-based approach to design small molecule drugs for convenient administration."  
markets: "Biotechnology, Pharmaceuticals, HealthTech, Life Sciences"  
hq: "Cambridge, Cambridgeshire, United Kingdom"  
founded_year: "2019"  
linkedin: "https://www.linkedin.com/company/loqus23-therapeutics-ltd"  
twitter: "https://twitter.com/loqus23"  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/loqus23-therapeutics"  
pitchbook: "https://pitchbook.com/profiles/company/277398-91"  

date_display: "02-Oct-2024"  
date: "2024-10-02"

# SEO Optimization  
meta_title: "LoQus23 Therapeutics - Series A Funding ($43M)"  
meta_description: "LoQus23 Therapeutics, LoQus23 Therapeutics is a biotechnology company developing small molecule drugs to stop DNA instability and slow neurodegeneration in Huntington's Dis..."  
meta_keywords: "LoQus23 Therapeutics, Biotechnology, Pharmaceuticals, HealthTech, Life Sciences, Series A funding"  
canonical_url: "https://startup.projectstartups.com/loqus23therapeuticsloqus23.com10022024/"  
---